Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Well
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Analytics
home
home
Medicines
Medicines
AI
Alphabet’s Isomorphic Labs has grand ambitions to ‘solve all diseases’ with AI. Now, it’s gearing up for its first human trials
By
Beatrice Nolan
July 6, 2025
Commentary
Why federal funding for life sciences—now being slashed—is a strategic necessity for America
By
Tiffany Wilson
April 17, 2025
Health
With RFK Jr. in charge, supplement makers see chance to cash in
By
KFF Health News
and
Arthur Allen
February 25, 2025
Health
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By
Bloomberg
,
Madison Muller
,
Ike Swetlitz
and
Naomi Kresge
February 21, 2025
Health
Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive
By
Lindsey Leake
February 15, 2025
Health
Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By
Lindsey Leake
February 11, 2025
Health
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
By
Lindsey Leake
February 7, 2025
Aging Well
Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug
By
Lindsey Leake
February 6, 2025
Commentary
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
By
Jeffrey Sonnenfeld
and
Steven Tian
February 5, 2025
Health
The aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits
By
Lindsey Leake
February 4, 2025
Health
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By
Lindsey Leake
February 3, 2025
Health
Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next
By
Lindsey Leake
January 29, 2025
Health
Mark Cuban once helped his college friend save almost $10,000 on prescriptions after a ‘horrific car accident’
By
Lindsey Leake
January 7, 2025
Newsletters
Cybersecurity leaders scramble to educate employees on generative AI threats
By
Sage Lazzaro
January 2, 2025
Newsletters
Bias in medical algorithms is one of AI’s long-running issues. Will new guidelines ignite action?
By
Sage Lazzaro
December 19, 2024
Most Popular
Economy
‘Fodder for a recession’: Top economist Mark Zandi warns about so many Americans ‘already living on the financial edge’...
By
Eva Roytburg
Success
When David Ellison was 13, his billionaire father Larry bought him a plane. He competed in air shows before leaving it...
By
Dave Smith
Banking
Jamie Dimon taps Jeff Bezos, Michael Dell, and Ford CEO Jim Farley to advise JPMorgan's $1.5 trillion national security...
By
Nino Paoli